[Antibiotic use in Mexico: review of problems and policies]

Anahí Dreser1, Veronika J Wirtz, Kitty K Corbett

  • 1Health Services Research Unit, London School of Hygiene and Tropical Medicine, Reino Unido.

Salud Publica De Mexico
|December 17, 2008
PubMed

Insights

Antibiotic misuse is a major public health issue, driving resistance and increasing costs. Mexico needs a comprehensive national strategy addressing consumers and the private sector, not just physicians.

Area of Science:

  • Public Health
  • Pharmaceutical Policy
  • Infectious Disease Epidemiology

Context:

  • Antibiotic resistance is a growing global threat, necessitating robust national strategies.
  • Mexico faces challenges with inappropriate antibiotic use, impacting individual health and resource allocation.
  • Current interventions primarily target physicians in public health services, with limited focus on consumers and the private sector.

Purpose:

  • To highlight the critical public health problem of antibiotic resistance driven by inappropriate use.
  • To analyze the current landscape of antibiotic use interventions in Mexico.
  • To identify gaps in research and policy concerning consumer and private sector antibiotic practices.

Summary:

  • Inappropriate antibiotic use fuels antibiotic resistance, a significant public health concern with increased mortality and healthcare costs.
  • Mexico's response has focused on public health physicians, neglecting crucial areas like consumer behavior and private sector engagement.
  • A comprehensive national antibiotic strategy integrated into health and pharmaceutical policies is lacking.

Impact:

  • Emphasizes the need for broader interventions beyond healthcare professionals to combat antibiotic resistance.
  • Underscores the importance of including consumer and private sector perspectives in national pharmaceutical policies.
  • Provides a foundation for developing more effective, multi-faceted strategies to improve antibiotic stewardship in Mexico.

Related Concept Videos

Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...